Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Despite the success of current therapies for acute myocardial infarction (MI), many patients still develop adverse cardiac remodeling and heart failure. With the growing prevalence of heart failure, a new therapy is needed that can prevent remodeling and support tissue repair. Herein, we report on i...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Sarah, McNeill, Brian, Podrebarac, James, Hosoyama, Katsuhiro, Sedlakova, Veronika, Cron, Gregory, Smyth, David, Seymour, Richard, Goel, Keshav, Liang, Wenbin, Rayner, Katey J., Ruel, Marc, Suuronen, Erik J., Alarcon, Emilio I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814728/
https://www.ncbi.nlm.nih.gov/pubmed/31653830
http://dx.doi.org/10.1038/s41467-019-12748-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814728/
https://www.ncbi.nlm.nih.gov/pubmed/31653830
http://dx.doi.org/10.1038/s41467-019-12748-8

Ejemplares similares